 During the course of derivatization of HTS hit 4a , we have identified a novel small-molecule hPTHR1 agonist , 1- ( 3,5-dimethyl-4- ( 2- ( ( 2- ( ( 1 R ,4 R) -4-methylcyclohexyl) -4-oxo-1,3,8-triazaspiro ( 4.5) dec-1-en-8-yl) sulfonyl) ethyl) phenyl) -1-methylurea ( CH5447240 , 14l). Compound 14l exhibited a potent in vitro hPTHR1 agonist effect with EC